NMC Health Plc
AGM and Dividend Timetable
London, 20 May 2019: NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, announces circulation of its Notice of 2019 Annual General Meeting and confirms details of the timetable for payment of its 2018 final dividend.
The Company's 2019 Annual General Meeting will be held on Thursday 20 June 2019, at 2:30pm at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD. A copy of the Notice of the 2019 Annual General Meeting Circular is today being posted to shareholders and has been submitted to the National Storage Mechanism and will be available for inspection at www.Morningstar.co.uk/uk/NSM. In addition, the Circular is available to view on the Company's website https://nmc.ae/finance/shareholder-information/notice-of-2019-annual-general-meeting.pdf
Following the 2018 financial year final results announcement of the Company made on 7 March 2019, in which the Board announced that it is recommending a final dividend of 18.1 pence per ordinary share, the Company hereby confirms the following timetable for payment of this dividend:
Ex-dividend date: 13 June 2019
Record date: 14 June 2019
Payment date: 10 July 2019
Payment of the final dividend remains subject to shareholder approval at the Company's 2019 Annual General Meeting.
Contacts
|
Investors
|
|
|
NMC |
|
|
Simon Watkins, Group Company Secretary |
+44 (0)20 3205 7313 |
|
|
|
|
Media |
|
|
FTI Consulting, London |
|
|
Brett Pollard |
+44 (0)20 3727 1000 |
|
|
|
|
FTI Consulting, Gulf |
|
|
Shane Dolan |
+971 (0)4 437 2100 |
|
|
|
About NMC Health plc
NMC the leading private healthcare operator in the GCC with an international network of hospitals across 19 countries. NMC also ranks as one of the top three in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, NMC has identified the Kingdom of Saudi Arabia (KSA) in particular as a key growth market, where the company has introduced long-term and multi-specialty care services. NMC received over 7.5m patients in 2018. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$2.1 billion for the year ended 31 December 2018.
In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
